Vitekta Approval History
Marketing Status: Discontinued
Vitekta (elvitegravir) is an integrase inhibitor for the combination treatment of HIV-1 infection in treatment-experienced adults.
Development History and FDA Approval Process for Vitekta
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.